0090003
print

Flecainide

FLEC
Example Reports
High
Therapeutic

Ordering Recommendation

Optimize drug therapy and monitor patient adherence.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation

Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.

Collect

Plain red. Also acceptable: Lavender (EDTA), pink (K2EDTA or K3EDTA), green (sodium or lithium heparin), or gray (sodium fluoride/potassium oxalate).

Specimen Preparation

Separate serum or plasma from cells within 6 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Gel separator tubes or gels of any kind; drug loss is immediate and no testing will be performed.

Remarks
Stability

After separation from cells: Ambient: 6 weeks; Refrigerated: 6 weeks; Frozen: 6 weeks

Methodology

Quantitative Liquid Chromatography-Tandem Mass Spectrometry

Performed

Mon, Thu, Sat

Reported

1-8 days

Reference Interval

Test Number
 Components
 Reference Interval
  Flecainide Therapeutic Range: 0.20-1.00 ug/mL
Toxic: > 1.50 ug/mL

Interpretive Data

Toxic concentrations may cause cardiac abnormalities, hypotension and seizure.

Compliance Category

Laboratory Developed Test (LDT)

Note

Hotline History

N/A

CPT Codes

80181

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
0090003 Flecainide 3638-4
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Almarytm
  • Apocard
  • Ecrinal
  • Flecaine
  • Tambocor
Flecainide